A dog rabies vaccination campaign in rural Africa: impact on the incidence of dog rabies and human dog-bite injuries

By Cleaveland S.   Kaare M.   Tiringa P.   Mlengeya T.   Barrat J.  

Vaccine, Vol. 21, Iss. 17, 2003-05 ,pp. : 1974-1982

Elsevier

Access to resources Recommend Favorite

Human adenovirus type 5 vectors expressing rabies glycoprotein

By Yarosh O.K.   Wandeler A.I.   Graham F.L.   Campbell J.B.   Prevec L.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1257-1264

Elsevier

Access to resources Recommend Favorite

A study of human rabies immune globulin manufactured by the Thai Red Cross

By Chantanakajornfung A.   Naraporn N.   Khumphai W.   Bejavongkulchai M.   Mitmoonpitak C.   Wilde H.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 979-981

Elsevier

Access to resources Recommend Favorite

Rabies - risk of exposure and current trends in prevention of human cases

By Haupt W.  

Vaccine, Vol. 17, Iss. 13, 1999-01 ,pp. : 1742-1749

Elsevier

Access to resources Recommend Favorite

Human diploid cell culture rabies vaccine (HDCV) and purified chick embryo cell culture rabies vaccine (PCECV) both confer protective immunity against infection with the silver-haired bat rabies virus strain (SHBRV)

By Dietzschold B.   Hooper D.C.  

Vaccine, Vol. 16, Iss. 17, 1998-10 ,pp. : 1656-1659

Elsevier

Access to resources Recommend Favorite